This article is more than 5 years old. Information may no longer be current.
MedStar Georgetown Cancer Institute appoints director
Louis M. Weiner, MD, has been named director of MedStar Georgetown Cancer Institute.
He will continue to serve as director of Georgetown Lombardi Comprehensive Cancer Center, the institute’s research engine.
In his new role, Weiner will oversee the development and coordination of clinical care and research programs that focus on prevention, treatment, rehabilitation, survivorship and end-of-life care across MedStar Health, the largest not-for-profit health care system in the Maryland and Washington, D.C., area.
Weiner specializes in the treatment of gastrointestinal cancers. His research focuses on the use of monoclonal antibodies and other immunotherapies.
“I am honored to have the opportunity to lead this effort,” Weiner said in a press release. “This is an exciting time for the field of cancer therapy, as new treatments are transforming the outlook for patients with this dreaded set of diseases.
“The MedStar Georgetown Cancer Institute links our nationally renowned cancer specialists across the Washington metropolitan region to offer the highest possible level of research-inspired cancer care, always maintaining the focus on the well-being of the patient,” he added. “The institute's alignment with the Georgetown Lombardi, one of the nation's National Cancer Institute-designated Comprehensive Cancer Centers, assures that our patients will always receive tomorrow's treatments today.”